{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:33:32Z","timestamp":1792784012680,"version":"4.5.0"},"reference-count":67,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372337"],"award-info":[{"award-number":["82372337"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82572661"],"award-info":[{"award-number":["82572661"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"},{"id":"https:\/\/ror.org\/01h0zpd94","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.gene.2026.150397","type":"journal-article","created":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T23:47:32Z","timestamp":1789516052000},"page":"150397","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Alternative splicing in Alzheimer\u2019s disease: event-level evidence, risk-locus biology, and RNA-based therapeutic perspectives"],"prefix":"10.1016","volume":"1013","author":[{"given":"Jinglin","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daoyuan","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenge","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhigang","family":"Xiong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4588-1898","authenticated-orcid":false,"given":"Xiong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150397_b0005","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnen\/nlw056","article-title":"Subcellular changes in bridging integrator 1 protein expression in the cerebral cortex during the progression of alzheimer disease pathology","volume":"75","author":"Adams","year":"2016","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.gene.2026.150397_b0010","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12928","article-title":"Increased intron retention is a post-transcriptional signature associated with progressive aging and Alzheimer's disease","volume":"18","author":"Adusumalli","year":"2019","journal-title":"Aging Cell"},{"key":"10.1016\/j.gene.2026.150397_b0015","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/jcp.22842","article-title":"Tau splicing and the intricacies of dementia","volume":"227","author":"Andreadis","year":"2012","journal-title":"J. Cell Physiol."},{"key":"10.1016\/j.gene.2026.150397_b0020","first-page":"326","article-title":"Interpretation of risk loci from genome-wide association studies of Alzheimer's disease","volume":"19","author":"Andrews","year":"2020","journal-title":"LancetNeurol"},{"key":"10.1016\/j.gene.2026.150397_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2025.106019","article-title":"Circular RNAs from the MAPT and TARDBP genes: Novel players in neurodegeneration?","volume":"189","author":"Bagheri","year":"2025","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.gene.2026.150397_b0030","doi-asserted-by":"crossref","first-page":"16562","DOI":"10.1073\/pnas.1310249110","article-title":"U1 small nuclear ribonucleoprotein complex and RNA splicing alterations in Alzheimer's disease","volume":"110","author":"Bai","year":"2013","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.gene.2026.150397_b0035","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nrm.2017.27","article-title":"Alternative splicing as a regulator of development and tissue identity","volume":"18","author":"Baralle","year":"2017","journal-title":"Nat. Rev.Mol Cell Biol"},{"key":"10.1016\/j.gene.2026.150397_b0040","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1126\/science.abq5622","article-title":"Mechanism of STMN2 cryptic splice-polyadenylation and its correction for TDP-43 proteinopathies","volume":"379","author":"Baughn","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.gene.2026.150397_b0045","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00401-021-02392-2","article-title":"Dysregulated coordination of MAPT exon 2 and exon 10 splicing underlies different tau pathologies in PSP and AD","volume":"143","author":"Bowles","year":"2022","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.gene.2026.150397_b0050","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/acn3.755","article-title":"Alternative splicing in a presenilin 2 variant associated with Alzheimer disease","volume":"6","author":"Braggin","year":"2019","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.gene.2026.150397_b0055","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/s41576-024-00774-2","article-title":"From computational models of the splicing code to regulatory mechanisms and therapeutic implications","volume":"26","author":"Capitanchik","year":"2025","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.gene.2026.150397_b0060","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13024-024-00751-7","article-title":"Identification of a specific APOE transcript and functional elements associated with Alzheimer's disease","volume":"19","author":"Chen","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.gene.2026.150397_b0065","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1038\/s41586-024-07310-6","article-title":"Antisense oligonucleotide therapeutic approach for Timothy syndrome","volume":"628","author":"Chen","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150397_b0070","doi-asserted-by":"crossref","unstructured":"Chen, Z.; Zhang, D.; Reynolds, R.H.; Gustavsson, E.K.; Garcia-Ruiz, S.; D'Sa, K.; Fairbrother-Browne, A.; Vandrovcova, J.; International Parkinson's Disease Genomics, C.; Hardy, J.; et al. Human-lineage-specific genomic elements are associated with neurodegenerative disease and APOE transcript usage. Nat. Commun. 2021, 12, 2076, doi:10.1038\/s41467-021-22262-5.","DOI":"10.1038\/s41467-021-22262-5"},{"key":"10.1016\/j.gene.2026.150397_b0075","doi-asserted-by":"crossref","DOI":"10.1111\/acel.14457","article-title":"Higher intron retention levels in female Alzheimer's brains may be linked to disease prevalence","volume":"24","author":"Choo","year":"2025","journal-title":"Aging Cell"},{"key":"10.1016\/j.gene.2026.150397_b0080","first-page":"424","article-title":"An intronic ncRNA-dependent regulation of SORL1 expression affecting Abeta formation is upregulated in post-mortem Alzheimer's disease brain samples","volume":"6","author":"Ciarlo","year":"2013","journal-title":"Dis. Model Mech."},{"key":"10.1016\/j.gene.2026.150397_b0085","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1093\/brain\/awac294","article-title":"Aberrant splicing of PSEN2, but not PSEN1, in individuals with sporadic Alzheimer's disease","volume":"146","author":"Course","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.gene.2026.150397_b0090","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-016-0124-1","article-title":"Predominant expression of Alzheimer's disease-associated BIN1 in mature oligodendrocytes and localization to white matter tracts","volume":"11","author":"De Rossi","year":"2016","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.gene.2026.150397_b0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13024-019-0319-3","article-title":"TREM2 brain transcript-specific studies in AD and TREM2 mutation carriers","volume":"14","author":"Del-Aguila","year":"2019","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.gene.2026.150397_b0100","first-page":"1344","article-title":"Exploratory Tau biomarker results from a multiple ascending-dose study of BIIB080 in Alzheimer disease: a randomized clinical trial","volume":"80","author":"Edwards","year":"2023","journal-title":"J. Am. Med. Assoc.Neurol"},{"key":"10.1016\/j.gene.2026.150397_b0105","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2023.1237874","article-title":"Analyzing alternative splicing in Alzheimer's disease postmortem brain: a cell-level perspective","volume":"16","author":"Farhadieh","year":"2023","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.gene.2026.150397_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1011348","article-title":"APOER2 splicing repertoire in Alzheimer's disease: Insights from long-read RNA sequencing","volume":"20","author":"Gallo","year":"2024","journal-title":"PLoS Genet"},{"key":"10.1016\/j.gene.2026.150397_b0115","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/s41467-024-55607-x","article-title":"Splicing accuracy varies across human introns, tissues, age and disease","volume":"16","author":"Garcia-Ruiz","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150397_b0120","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/j.1471-4159.2005.03552.x","article-title":"The alternative splicing of tau exon 10 and its regulatory proteins CLK2 and TRA2-BETA1 changes in sporadic Alzheimer's disease","volume":"96","author":"Glatz","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.gene.2026.150397_b0125","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aeb8517","article-title":"Cryptic splicing in synaptic and membrane excitability genes links TDP-43 loss to neuronal dysfunction","volume":"18","author":"Guo","year":"2026","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.gene.2026.150397_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12920-018-0453-8","article-title":"for Alzheimer's Disease Neuroimaging, I. Identification of exon skipping events associated with Alzheimer's disease in the human hippocampus","volume":"12","author":"Han","year":"2019","journal-title":"BMC Med. Genomics"},{"key":"10.1016\/j.gene.2026.150397_b0135","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21197079","article-title":"Alternative splicing regulation of an Alzheimer's risk variant in CLU","volume":"21","author":"Han","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150397_b0140","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22189865","article-title":"Alternative splicing regulation of low-frequency genetic variants in Exon 2 of TREM2 in Alzheimer's disease by splicing-based aggregation","volume":"22","author":"Han","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.gene.2026.150397_b0145","doi-asserted-by":"crossref","first-page":"328","DOI":"10.15252\/emmm.201505846","article-title":"Therapeutic correction of ApoER2 splicing in Alzheimer's disease mice using antisense oligonucleotides","volume":"8","author":"Hinrich","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.gene.2026.150397_b0150","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/JLB.2HI0720-463RR","article-title":"Novel TREM2 splicing isoform that lacks the V-set immunoglobulin domain is abundant in the human brain","volume":"110","author":"Kiianitsa","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.gene.2026.150397_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.150025","article-title":"Gene-gene functional relationships in Alzheimer's disease: CELF1 regulates KLC1 alternative splicing","volume":"721","author":"Kikuchi","year":"2024","journal-title":"Biochem. Biophys Res Commun"},{"key":"10.1016\/j.gene.2026.150397_b0160","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1038\/s41586-023-06277-0","article-title":"A framework for individualized splice-switching oligonucleotide therapy","volume":"619","author":"Kim","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150397_b0165","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1101\/gr.281117.125","article-title":"Allele-specific splicing modulates protein isoforms and Alzheimer's disease risk","volume":"36","author":"King","year":"2026","journal-title":"Genome Res."},{"key":"10.1016\/j.gene.2026.150397_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/cells12040602","article-title":"Alzheimer's disease-associated alternative splicing of CD33 is regulated by the HNRNPA family proteins","volume":"12","author":"Komuro","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.gene.2026.150397_b0175","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41586-025-09486-x","article-title":"PICALM Alzheimer's risk allele causes aberrant lipid droplets in microglia","volume":"646","author":"Kozlova","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150397_b0180","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1093\/hmg\/ddaf153","article-title":"Determining off-target effects of splice-switching antisense oligonucleotides using short read RNAseq in neuronally differentiated human induced pluripotent stem cells","volume":"34","author":"Kuijper","year":"2025","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.gene.2026.150397_b0185","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neulet.2017.04.014","article-title":"Targeted sequencing of ABCA7 identifies splicing, stop-gain and intronic risk variants for Alzheimer disease","volume":"649","author":"Kunkle","year":"2017","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.gene.2026.150397_b0190","doi-asserted-by":"crossref","first-page":"30085","DOI":"10.1038\/s41598-024-81687-2","article-title":"Effects of the therapeutic correction of U1 snRNP complex on Alzheimer's disease","volume":"14","author":"Leal","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.gene.2026.150397_b0195","doi-asserted-by":"crossref","first-page":"6458","DOI":"10.1038\/s41467-024-50486-8","article-title":"Long-read transcript sequencing identifies differential isoform expression in the entorhinal cortex in a transgenic model of tau pathology","volume":"15","author":"Leung","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150397_b0200","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/alz.12254","article-title":"Integrative functional genomic analysis of intron retention in human and mouse brain with Alzheimer's disease","volume":"17","author":"Li","year":"2021","journal-title":"Alzheimers. Dement."},{"key":"10.1016\/j.gene.2026.150397_b0205","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s44318-024-00352-6","article-title":"RNA dysregulation in neurodegenerative diseases","volume":"44","author":"Li","year":"2025","journal-title":"EMBO J."},{"key":"10.1016\/j.gene.2026.150397_b0210","doi-asserted-by":"crossref","DOI":"10.1523\/ENEURO.0296-24.2024","article-title":"RNA isoform diversity in human neurodegenerative diseases","volume":"11","author":"Liu","year":"2024","journal-title":"eNeuro"},{"key":"10.1016\/j.gene.2026.150397_b0215","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150397_b0220","doi-asserted-by":"crossref","first-page":"6554","DOI":"10.18632\/aging.204223","article-title":"Distinct microglia alternative splicing in Alzheimer's disease","volume":"14","author":"Lu","year":"2022","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.gene.2026.150397_b0225","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1038\/s41586-019-1195-2","article-title":"Single-cell transcriptomic analysis of Alzheimer's disease","volume":"570","author":"Mathys","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150397_b0230","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1056\/NEJMoa2204705","article-title":"Trial of antisense oligonucleotide tofersen for SOD1 ALS","volume":"387","author":"Miller","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.gene.2026.150397_b0235","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40478-021-01140-7","article-title":"Expression of an alternatively spliced variant of SORL1 in neuronal dendrites is decreased in patients with Alzheimer's disease","volume":"9","author":"Monti","year":"2021","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.gene.2026.150397_b0240","doi-asserted-by":"crossref","first-page":"7109","DOI":"10.1093\/nar\/gkad371","article-title":"A single-cell map of antisense oligonucleotide activity in the brain","volume":"51","author":"Mortberg","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150397_b0245","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1038\/s41591-023-02326-3","article-title":"Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer's disease: a phase 1b, randomized, placebo-controlled trial","volume":"29","author":"Mummery","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.gene.2026.150397_b0250","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2204179119","article-title":"Truncated Tau caused by intron retention is enriched in Alzheimer's disease cortex and exhibits altered biochemical properties","volume":"119","author":"Ngian","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.gene.2026.150397_b0255","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1038\/s41583-023-00717-6","article-title":"Alternative splicing in neurodegenerative disease and the promise of RNA therapies","volume":"24","author":"Nikom","year":"2023","journal-title":"Nat. Rev.Neurosci"},{"key":"10.1016\/j.gene.2026.150397_b0260","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1126\/science.2457949","article-title":"Amyloid protein precursor messenger RNAs: differential expression in Alzheimer's disease","volume":"241","author":"Palmert","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.gene.2026.150397_b0265","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-9-32","article-title":"An intronic PICALM polymorphism, rs588076, is associated with allelic expression of a PICALM isoform","volume":"9","author":"Parikh","year":"2014","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.gene.2026.150397_b0270","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s41398-020-01175-9","article-title":"A cortical immune network map identifies distinct microglial transcriptional programs associated with beta-amyloid and Tau pathologies","volume":"11","author":"Patrick","year":"2021","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.gene.2026.150397_b0275","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41576-021-00439-4","article-title":"Drug delivery systems for RNA therapeutics","volume":"23","author":"Paunovska","year":"2022","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.gene.2026.150397_b0280","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00401-023-02655-0","article-title":"Cryptic splicing of stathmin-2 and UNC13A mRNAs is a pathological hallmark of TDP-43-associated Alzheimer's disease","volume":"147","author":"Quadros","year":"2024","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.gene.2026.150397_b0285","doi-asserted-by":"crossref","first-page":"2729","DOI":"10.1093\/hmg\/ddt666","article-title":"CD33: increased inclusion of exon 2 implicates the Ig V-set domain in Alzheimer's disease susceptibility","volume":"23","author":"Raj","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.gene.2026.150397_b0290","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1038\/s41588-018-0238-1","article-title":"Integrative transcriptome analyses of the aging brain implicate altered splicing in Alzheimer's disease susceptibility","volume":"50","author":"Raj","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150397_b0295","doi-asserted-by":"crossref","first-page":"28257","DOI":"10.1074\/jbc.270.47.28257","article-title":"Levels and alternative splicing of amyloid beta protein precursor (APP) transcripts in brains of APP transgenic mice and humans with Alzheimer's disease","volume":"270","author":"Rockenstein","year":"1995","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2026.150397_b0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuron.2025.11.022","article-title":"The Alzheimer's disease risk genes MS4A4A and MS4A6A cooperate to negatively regulate TREM2 and microglia states","volume":"114","author":"Rosner","year":"2026","journal-title":"Neuron"},{"key":"10.1016\/j.gene.2026.150397_b0305","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/S0140-6736(26)00198-4","article-title":"Alzheimer's disease","volume":"407","author":"Serrano-Pozo","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/j.gene.2026.150397_b0310","doi-asserted-by":"crossref","first-page":"9466","DOI":"10.1038\/s41467-025-64525-5","article-title":"Sex-specific associations of gene expression with Alzheimer's disease neuropathology and ante-mortem cognitive performance","volume":"16","author":"Seto","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150397_b0315","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1038\/tp.2011.17","article-title":"Alzheimer's risk variants in the clusterin gene are associated with alternative splicing","volume":"1","author":"Szymanski","year":"2011","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.gene.2026.150397_b0320","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0016266","article-title":"Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease","volume":"6","author":"Twine","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150397_b0325","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13073-024-01404-6","article-title":"Identification of pathological pathways centered on circRNA dysregulation in association with irreversible progression of Alzheimer's disease","volume":"16","author":"Wang","year":"2024","journal-title":"Genome Med."},{"key":"10.1016\/j.gene.2026.150397_b0330","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1191680","article-title":"Comprehensive transcript-level analysis reveals transcriptional reprogramming during the progression of Alzheimer's disease","volume":"15","author":"Wu","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.gene.2026.150397_b0335","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70545","article-title":"Alternative splicing: molecular mechanisms, biological functions, diseases, and potential therapeutic targets","volume":"6","author":"Zhu","year":"2025","journal-title":"MedComm"}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926004075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926004075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T08:29:02Z","timestamp":1790584142000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926004075"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":67,"alternative-id":["S0378111926004075"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150397","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alternative splicing in Alzheimer\u2019s disease: event-level evidence, risk-locus biology, and RNA-based therapeutic perspectives","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150397","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150397"}}